Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison. [electronic resource]
Producer: 20150330Description: 650-5 p. digitalISSN:- 1442-9071
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bevacizumab
- Dexamethasone -- administration & dosage
- Drug Implants
- Female
- Fluorescein Angiography
- Glucocorticoids -- administration & dosage
- Humans
- Intraocular Pressure
- Intravitreal Injections
- Macular Edema -- drug therapy
- Male
- Middle Aged
- Prospective Studies
- Retinal Vein Occlusion -- complications
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.